The Investor Relations website contains information about Agile Therapeutics's business for stockholders, potential investors, and financial analysts.
People also ask
Is AGRX a good investment?
Why is Agile Therapeutics stock dropping?
How many employees does AGRX have?
Did Agile Therapeutics announce exercise of warrants for $4.8 million gross proceeds?
(Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before the market opens on ...
$0.35
Get the latest insights on Agile Therapeutics Inc. (AGRX) with press releases and corporate news to help you in your trading and investing decisions.
(Nasdaq: AGRX), a women's healthcare company, today reported financial ... Annual Report on Form 10-K and ... Head of Investor Relations & Corporate Communications
Institutional Holdings - Agile Therapeutics Inc. (AGRX) - Nasdaq
www.nasdaq.com › ... › Stocks › AGRX
Find the latest institutional holdings data for Agile Therapeutics Inc. (AGRX) including shareholders, ownership summaries, and holding activities at ...
Find the latest Agile Therapeutics, Inc. (AGRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Nov 10, 2023 · Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 ... Investor Relations. ADVERTISEMENT ... Shares of This ...
Agile Therapeutics (AGRX) Investor Presentation - Slideshow · SA TranscriptsTue, Sep. 10, 2019. Agile Therapeutics (AGRX) Investor Presentation - Slideshow · SA ...
Agile Therapeutics Releases Updated Investor Presentation. TipRanksApr 9 05:43 · Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript.
Company profile for Agile Therapeutics, Inc. (AGRX) with ... AGRX. Exchange, OTCMKTS. Fiscal Year, January ... Head of Investor Relations and Corporate ...